Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000754 |
| _version_ | 1797287198605705216 |
|---|---|
| author | Lennart Lenk Dorothee Winterberg Fotini Vogiatzi Anna Laqua Lea Spory Ahmad Mayar Anna Dietterle Gina Münch Christian Vokuhl Julia Richter Andrew G. Polson Thomas Schüler Ulf D. Kahlert Matthias Peipp Thomas Valerius Martin Schrappe Gunnar Cario Hassan Jumaa Elias Hobeika Monika Brüggemann Ameera Alsadeq Denis M. Schewe |
| author_facet | Lennart Lenk Dorothee Winterberg Fotini Vogiatzi Anna Laqua Lea Spory Ahmad Mayar Anna Dietterle Gina Münch Christian Vokuhl Julia Richter Andrew G. Polson Thomas Schüler Ulf D. Kahlert Matthias Peipp Thomas Valerius Martin Schrappe Gunnar Cario Hassan Jumaa Elias Hobeika Monika Brüggemann Ameera Alsadeq Denis M. Schewe |
| author_sort | Lennart Lenk |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:29:29Z |
| format | Article |
| id | doaj.art-ee2a0191775641108c609751c3210508 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:29:29Z |
| publishDate | 2022-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-ee2a0191775641108c609751c32105082024-03-02T06:41:34ZengWileyHemaSphere2572-92412022-08-0168e75410.1097/HS9.0000000000000754202208000-00005Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic LeukemiaLennart Lenk0Dorothee Winterberg1Fotini Vogiatzi2Anna Laqua3Lea Spory4Ahmad Mayar5Anna Dietterle6Gina Münch7Christian Vokuhl8Julia Richter9Andrew G. Polson10Thomas Schüler11Ulf D. Kahlert12Matthias Peipp13Thomas Valerius14Martin Schrappe15Gunnar Cario16Hassan Jumaa17Elias Hobeika18Monika Brüggemann19Ameera Alsadeq20Denis M. Schewe211 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany2 Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany3 Department of Pathology, Section of Pediatric Pathology, University Hospital Bonn, Germany4 Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany5 Genentech Research and Early Development, San Francisco, CA, USA6 Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-Von-Guericke University Magdeburg, Germany7 Molecular and Experimental Surgery, Clinic for General, Visceral, Vascular, and Transplant Surgery, Medical Faculty, University Hospital Magdeburg, Germany8 Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany9 Department of Medicine II, Section for Stem Cell Transplantation and Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany2 Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germanyhttp://journals.lww.com/10.1097/HS9.0000000000000754 |
| spellingShingle | Lennart Lenk Dorothee Winterberg Fotini Vogiatzi Anna Laqua Lea Spory Ahmad Mayar Anna Dietterle Gina Münch Christian Vokuhl Julia Richter Andrew G. Polson Thomas Schüler Ulf D. Kahlert Matthias Peipp Thomas Valerius Martin Schrappe Gunnar Cario Hassan Jumaa Elias Hobeika Monika Brüggemann Ameera Alsadeq Denis M. Schewe Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia HemaSphere |
| title | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
| title_full | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
| title_fullStr | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
| title_full_unstemmed | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
| title_short | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
| title_sort | preclinical evidence for the efficacy of cd79b immunotherapy in b cell precursor acute lymphoblastic leukemia |
| url | http://journals.lww.com/10.1097/HS9.0000000000000754 |
| work_keys_str_mv | AT lennartlenk preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT dorotheewinterberg preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT fotinivogiatzi preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT annalaqua preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT leaspory preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT ahmadmayar preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT annadietterle preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT ginamunch preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT christianvokuhl preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT juliarichter preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT andrewgpolson preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT thomasschuler preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT ulfdkahlert preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT matthiaspeipp preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT thomasvalerius preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT martinschrappe preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT gunnarcario preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT hassanjumaa preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT eliashobeika preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT monikabruggemann preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT ameeraalsadeq preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT denismschewe preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia |